DNA cirulante de tumor como biomarcador em pacientes com tumor de Wilms estágios III e IV.
14 Jun, 2022 | 13:33hComentário: Analysis of Circulating Tumor DNA as a Biomarker in Stage III and IV Wilms Tumor – The ASCO Post
Comentário: Analysis of Circulating Tumor DNA as a Biomarker in Stage III and IV Wilms Tumor – The ASCO Post